Outlook Therapeutics, Inc. (OTLK)
0.414
-0.02
(-4.12%)
USD |
NASDAQ |
Mar 06, 16:00
0.4141
0.00 (0.00%)
After-Hours: 20:00
Outlook Therapeutics SG&A Expense (TTM) : 38.22M for Dec. 31, 2025
SG&A Expense (TTM) Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Data
SG&A Expense (TTM) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
SG&A Expense (TTM) Benchmarks
| Ironwood Pharmaceuticals, Inc. | 82.26M |
| Amicus Therapeutics, Inc. | 383.49M |
| CorMedix, Inc. | 60.19M |
| ACADIA Pharmaceuticals, Inc. | 548.89M |
| Alnylam Pharmaceuticals, Inc. | 1.211B |